RTHP-14. TREATMENT RESULTS OF STEREOTACTIC RADIOTHERAPY AND BEVACIZUMAB (SRT-Bv) FOR RECURRENT GLIOBLASTOMA
CONCLUSION:SRT with bevacizumab is a safe and considerable treatment option for recurrent glioblastoma.
Source: Neuro-Oncology - Category: Cancer & Oncology Authors: Yasuda, T., Nitta, M., Maruyama, T., Tsuduki, S., Muragaki, Y., Kawamata, T. Tags: RADIATION THERAPY Source Type: research
More News: Aphasia | Avastin | Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Chemotherapy | Neurology | Radiation Therapy | Statistics | Study